Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Return on Capital %

Arena Pharmaceutical Return on Capital % Chart (ARNA)

Arena Pharmaceutical annual/quarterly Return on Capital % from 2000 to 2018.
  • Arena Pharmaceutical Return on Capital % for the quarter ending September 09, 2018 was -14.88 a 16.87% decrease of -2.51 year over year
  • Arena Pharmaceutical Return on Capital % for the last 12 months ending September 09, 2018 was -16.31 a -63.71% increase of 10.39 year over year
  • Arena Pharmaceutical Annual Return on Capital % for 2017 was -26.70 a 101.75% decrease of -27.16 from 2016
  • Arena Pharmaceutical Annual Return on Capital % for 2016 was 0.47 a 11,248.70% increase of 52.67 from 2015
  • Arena Pharmaceutical Annual Return on Capital % for 2015 was -52.20 a 10.84% decrease of -5.66 from 2014
Other Margins & Efficiency Metrics:
  • Arena Pharmaceutical EBITDA Margin for the quarter ending December 12, 2017 was $-82m a -245.61% increase of 200m year over year
  • Arena Pharmaceutical Return on Equity % for the quarter ending September 09, 2018 was -25.18 a -6.61% increase of 1.66 year over year
View Chart On Koyfin

Quarterly ARNA Return on Capital % Data

09/2018-14.88
06/2018-13.11
03/2018-16.93
12/2017-12.37
09/2017-26.04
06/2017-48.38
03/2017-53.88
09/2016-31.98
06/2016-54.20
03/2016-42.30

Annual ARNA Return on Capital % Data

2017-26.70
20160.47
2015-52.20
2014-46.54
2013-8.49
2012-26.04
2011-32.35
2010-28.78
2009-41.98
2008-45.95